Commonwealth Coat of Arms of Australia

National Health (Prescriber Bag Supplies) Determination 2024

PB 29 of 2024

made under sections 93 and 93AB of the

National Health Act 1953

Compilation No. 2

Compilation date: 1 February 2025

Includes amendments: F2025L00065

About this compilation

This compilation

This is a compilation of the National Health (Prescriber Bag Supplies) Determination 2024 that shows the text of the law as amended and in force on 1 February 2025 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.

Selfrepealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

 

Part 1—Preliminary

1 Name

3 Authority

4 Definitions

5 References to a pharmaceutical benefit that has a drug in a relevant form

Part 2—Authorisation of practitioners and maximum quantity (number of units)

6 Authorisation of practitioners to supply pharmaceutical benefits

7 Maximum quantity (number of units)

Schedule 1—Pharmaceutical benefits that may be supplied by authorised suppliers

Endnotes

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

 

 (1) This instrument is the National Health (Prescriber Bag Supplies) Determination 2024.

 (2) This instrument may also be cited as PB 29 of 2024.

  This instrument is made under sections 93 and 93AB of the National Health Act 1953.

Note 1: Under subsection 4(1A) of the Act, a word or phrase defined for the purposes of the Health Insurance Act 1973 has the meaning that it would have if used in that Act. Expressions used in this instrument that are defined in that Act include ‘medical practitioner’.

In this instrument:

Act means the National Health Act 1953.

authorised nurse practitioner has the same meaning as in Part VII of the Act.

pharmaceutical benefit has the same meaning as in Part VII of the Act.

pharmaceutical benefit has a drug has the same meaning as in Part VII of the Act.

pharmaceutical benefit that has a drug in a relevant form: see section 5.

A reference in this instrument to a pharmaceutical benefit that has a drug in a relevant form is a reference to a pharmaceutical benefit that has a drug mentioned in an item in Schedule 1 in the column headed “Listed Drug” in the form mentioned for that drug in the column in Schedule 1 headed “Form”.

 (1) For the purposes of subsection 93(1) of the Act, a medical practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “MP” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”.

 (2) For the purposes of subsection 93AB(1) of the Act, an authorised nurse practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “NP” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”.

 (1) This section determines the maximum number of units of a pharmaceutical benefit that has a drug in a relevant form which may be obtained by a medical practitioner or an authorised nurse practitioner (a practitioner) in a calendar month for the purposes of subsection 93(2) and subsection 93AB(2) of the Act.

 (2) The maximum number of units is the number of units mentioned in the column in Schedule 1 headed “Maximum Quantity” for that drug in that form.

 (3) Despite subsection (2), if a practitioner has already obtained 1 or more units of a pharmaceutical benefit that has a drug in a relevant form in a group in the same calendar month, the maximum number of units of any other pharmaceutical benefit that has a drug in a relevant form in that group is zero for that calendar month.

 (4) For this section, a group is each pharmaceutical benefit that has a drug in a relevant form which has the same number mentioned for the drug and form in the column in Schedule 1 headed “Group Number”.

 

Group Number

Listed Drug

Form

Prescriber Bag Supplier

Maximum Quantity

1

Adrenaline (epinephrine)

Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000)

MP, NP

5

3

Atropine

Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL

MP, NP

10

58

Benzathine benzylpenicillin

Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use prefilled syringe

MP, NP

10

58

Benzathine benzylpenicillin

Powder for injection 1,200,000 units with diluent 5 mL (S19A)

MP, NP

10

31

Benzatropine

Injection containing benzatropine mesilate 2 mg in 2 mL

MP, NP

5

17

Benzylpenicillin

Powder for injection 600 mg (as sodium)

MP, NP, MW

5

32

Benzylpenicillin

Powder for injection 3 g (as sodium)

MP, NP, MW

1

4

Chlorpromazine

Injection containing chlorpromazine hydrochloride 50 mg in 2 mL

MP, NP

10

34

Clonazepam

Oral liquid 2.5 mg per mL, 10 mL

MP, NP

1

25

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

Injection 0.5 mL in prefilled syringe

MP, NP

10

10

Furosemide

Injection 20 mg in 2 mL

MP, NP

5

60

Furosemide

Tablet 20 mg

MP, NP

50

26

Glucagon

Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe

MP, NP

1

30

Glyceryl Trinitrate

Sublingual spray (pump pack) 400 micrograms per dose, 200 doses

MP, NP

1

4

Haloperidol

Injection 5 mg in 1 mL

MP, NP

10

12

Hydrocortisone

Injection 100 mg (as sodium succinate) with 2 mL solvent

MP, NP

2

12

Hydrocortisone

Injection 250 mg (as sodium succinate) with 2 mL solvent

MP, NP

1

33

Hyoscine

Injection containing hyoscine butylbromide 20 mg in 1 mL

MP, NP

5

54

Lidocaine

Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL

MP, NP, MW

5

35

Methoxyflurane

Liquid for inhalation 999 mg per g, 3 mL (with inhaler)

MP

1

18

Metoclopramide

Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL

MP, NP

10

53

Midazolam

Injection 5 mg (as hydrochloride) in 1 mL

MP, NP

10

62

Molnupiravir

Capsule 200 mg

MP, NP

80

14

Morphine

Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL

MP, NP

5

14

Morphine

Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL

MP, NP

5

14

Morphine

Injection containing morphine sulfate pentahydrate 15 mg in 1 mL

MP, NP

5

14

Morphine

Injection containing morphine sulfate pentahydrate 30 mg in 1 mL

MP, NP

5

57

Naloxone

Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule

MP, NP, MW

10

61

Nirmatrelvir and ritonavir

Pack containing 4 tablets nirmatrelvir 150 mg and 2 tablets ritonavir 100 mg, 5

MP, NP

2

55

Phytomenadione

Injection 10 mg in 1 mL

MP

5

18

Prochlorperazine

Injection containing prochlorperazine mesilate 12.5 mg in 1 mL

MP, NP, MW

10

19

Promethazine

Injection containing promethazine hydrochloride 50 mg in 2 mL

MP, NP, MW

10

59

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

MP, NP

1

59

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 (S19A)

MP, NP

1

59

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

MP, NP

1

28

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

MP, NP

1

28

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

MP, NP

1

59

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFCfree formulation)

MP, NP

1

16

Tramadol

Injection containing tramadol hydrochloride 100 mg in 2 mL

MP, NP

5

 

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.

If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

/subsubparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

ed = editorial change

reloc = relocated

exp = expires/expired or ceases/ceased to have

renum = renumbered

effect

rep = repealed

F = Federal Register of Legislation

rs = repealed and substituted

gaz = gazette

s = section(s)/subsection(s)

LA = Legislation Act 2003

Sch = Schedule(s)

LIA = Legislative Instruments Act 2003

Sdiv = Subdivision(s)

(md) = misdescribed amendment can be given

SLI = Select Legislative Instrument

effect

SR = Statutory Rules

(md not incorp) = misdescribed amendment

SubCh = SubChapter(s)

cannot be given effect

SubPt = Subpart(s)

mod = modified/modification

underlining = whole or part not

No. = Number(s)

commenced or to be commenced

 

 

Name

Registration

Commencement

Application, saving and transitional provisions

National Health (Prescriber Bag Supplies) Determination 2024 (PB 29 of 2024)

28 Mar 2024 (F2024L00414)

1 Apr 2024 (s 2(1) item 1)

 

National Health (Prescriber Bag Supplies) Amendment (May Update) Determination 2024 (PB 42 of 2024)

30 Apr 2024 (F2024L00503)

1 May 2024 (s 2(1) item 1)

National Health (Prescriber bag supplies) Amendment (February Update) Determination 2025 (PB 4 of 2025)

31 Jan 2025 (F2025L00065)

1 Feb 2025 (s 2(1) item 1)

 

 

Provision affected

How affected

Part 1

 

s 2.....................

rep LA s 48D

Schedule 1

 

Schedule 1................

am F2024L00503; F2025L00065